Zetia News
Most Popular Zetia Story
Merck's new label for Vytorin disappoints the analysts
The FDA approved a label change that recognizes how Vytorin can prevent heart problems among chronic kidney disease patients, butdidn't specifically give it an approval for that indication. Now Merck Read more...
Latest Headlines
- January 25, 2012
- October 31, 2011
- October 12, 2011
- July 11, 2011
- April 22, 2010
- December 23, 2009
- November 25, 2009
- November 17, 2009
- November 10, 2009
- July 20, 2009
- July 10, 2009
- July 9, 2009
- November 17, 2008
- September 11, 2008
- May 29, 2008
- March 18, 2008
- March 14, 2008
- February 15, 2008
- January 23, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
